Vitamin K2 Supplements Market Expands with Growing Awareness of Bone and Heart Health

The global vitamin K2 supplements market is anticipated to reach USD 3.06 billion by 2030 and is anticipated to grow at a CAGR of 12.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. This growth is largely driven by increasing consumer interest in the health benefits of vitamin K2, particularly for bone and dental health, and its potential protective effects against certain cancers. Despite challenges in obtaining sufficient vitamin K2 through diet alone, supplements offer a convenient alternative, especially when combined with vitamin D to enhance effectiveness. However, the market faces stability issues, as natural-fermented K2 MK-7 can degrade over time, impacting product efficacy and consumer trust. Innovations such as microencapsulation are crucial in addressing these stability concerns, ensuring product reliability and supporting ongoing market expansion.

Consumer preferences for organic and sustainable products are also shaping the demand for MK-7 supplements. Raw material suppliers are adapting to this trend by developing innovative solutions. For instance, Kappa Bioscience introduced K2Vital MCT Organic at SupplySide West 2022, the first USDA organic-certified vitamin K2-MK7. This product meets the growing demand for organic supplements by being allergen-free, vegan, and non-GMO, offered in a liquid oil form with a 36-month shelf life.

The robust growth in the market is further fueled by the increasing recognition of its combined benefits with vitamin D3. This synergy between vitamin D3 and K2 enhances bone strength, supports cardiovascular health, and may provide additional immune benefits. The market is also benefiting from innovations in supplement formulations, such as double-encapsulated K2 products, which improve stability and effectiveness. The expanding consumer awareness of these benefits is driving up demand for MK-7, known for its superior bioavailability and longer half-life.

Get a preview of the latest developments in the Vitamin K2 Supplements Market! Download your FREE sample PDF today and explore key data and trends

Moreover, the potential for significant healthcare cost savings associated with vitamin K2 supplementation influences the market positively. The Council for Responsible Nutrition estimates that broader use of vitamin K2 could reduce coronary artery disease events by 15.7% and save the U.S. healthcare system approximately USD 9.48 billion annually. This potential for cost savings, coupled with growing consumer interest and investment in vitamin K2 supplements, highlights its emerging role in preventive healthcare.

Key players like Kappa Bioscience are at the forefront, offering advanced products like K2VITAL, which cater to the demand for high-quality, bioactive vitamin K2. As the scientific evidence supporting the health benefits of vitamin K2 continues to grow, the market is evolving with an emphasis on product purity, effectiveness, and comprehensive consumer education.

Vitamin K2 Supplements Market Report Highlights

• Based on product, MK-7 supplements accounted for 85.3% revenue share in 2023, primarily due to their superior bioavailability and longer half-life compared to MK-4. MK-7’s extended presence in the bloodstream enhances its effectiveness in supporting bone health and reducing arterial calcification. Its growing recognition for preventing cardiovascular diseases and osteoporosis, especially among aging populations and regions with a strong focus on preventive healthcare, has significantly boosted its demand.

• Based on application, the demand for vitamin K2 supplements for cardiovascular health is expected to grow at a CAGR of 13.3% from 2024 to 2030. Recent studies emphasize vitamin K2’s potential in enhancing heart health, with MK-7 proven to improve arterial flexibility and reduce arterial calcification by activating Matrix GLA Protein (MGP). A 2023 study demonstrated that daily MK-7 supplementation improved vessel elasticity and blood pressure, particularly in women, and could lead to significant healthcare cost savings.

• Based on distribution channel, pharmacies and drugstores accounted for over 30% of vitamin K2 supplement sales in 2023. This strong performance is attributed to their wide customer reach and established reputation for offering reliable health products. These outlets provide convenient access and expert advice, boosting consumer confidence and purchases.

• Based on region, in 2023, the market for vitamin K2 supplements in North America held a revenue share of 36.7%, driven by a strong focus on cardiovascular and bone health. This is fueled by rising health awareness and preventive healthcare trends. The region benefits from extensive retail and e-commerce networks that ensure broad access to vitamin K2 products.

• In April 2023, Petrovax Pharm, a biotech company launched SunDevit, a new vitamin complex combining D3 and K2 in Russia. This innovative product enhances calcium distribution for bone health while preventing calcium buildup in blood vessels. The product supports the immune system, muscles, bones, and joint health. SunDevit is designed for adults and offers an optimal dosage of 2000 IU of vitamin D3 per serving.

List of Key Players in the Vitamin K2 Supplements Market

• NOW Health Group, Inc.
• Doctor’s Best
• Solgar Inc.
• Jarrow Formulas, Inc.
• Pure Encapsulations
• Pharmavite LLC (Nature Made)
• Liposoma BV
• Vital Nutrients
• Thorne
• Healthy Origins USA

Gather more insights about the market drivers, restrains and growth of the Global Vitamin K2 Supplements Market